UNSPSC 51111759: Piroxantrone

This classification denotes an anthrapyrazole antibiotic with the molecular formula C21H25N5O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YL4TY9WH22, chemically known as anthra(1,9-cd)pyrazol-6(2h)-one, 5-((3-aminopropyl)amino)-7,10-dihydroxy-2-(2-((2-hydroxyethyl)amino)ethyl)- but generally known as piroxantrone, which bears US NIH Compound Identifier 5362372. European Medicines Agency schedules Piroxantrone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09935MIG.

UNSPSC 51111759 Piroxantrone, a Commodity code, nominally identifies a specific chemotherapy agent, but recent state and local solicitations tagged under this code actually procure a much broader range of pharmaceutical products and medical supplies—naloxone, medical and first aid supplies for emergency response, generic pharmaceuticals, and over-the-counter products. State and local governments use this code to acquire medications and medical consumables for health departments, fire-rescue divisions, and multistate cooperative purchasing programs that serve government health benefit plans and facility-based distribution networks. Issuing bodies span county health departments (Seminole County, Florida), city fire rescue services (City of Tampa), state health agencies (Texas Health and Human Services Commission), and cooperative purchasing alliances serving multiple states and localities (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). The range of solicitation types—from competitive sealed bids for single-jurisdiction supply to multistate RFPs for pharmaceutical manufacturers and RFIs exploring direct-to-manufacturer contracting models—signals that the commodity code is used to tag both routine consumables procurement and strategic sourcing of pharmaceutical supply-chain relationships.

Recent activity concentrates in Florida, Texas, and Minnesota, with MMCAP's multistate reach extending to participating states including Oregon. Representative solicitations include Seminole County's IFB60459723LAS (posted June 30, 2026; due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding with quarterly deliveries to the Seminole County Community Health Building; the City of Tampa's ITB 26P00145 (posted March 25, 2026; due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000 and a sheltered-market set-aside for certified Small Local Business Enterprises (SLBEs) offering a 5 percent bid discount not to exceed $10,000; MMCAP's RFP S1070000015802 (posted January 20, 2026; due March 26, 2026) establishing multiple contracts for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers with a July 1, 2026 effective date; and the Texas Health and Human Services Commission's RFI HHS0017013 (posted April 3, 2026; due April 3, 2026) exploring vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program.